Trademark: 86583898
Status Date
Monday, April 26, 2021
Filing Date
Wednesday, April 1, 2015
Published for Opposition
Tuesday, January 23, 2018
Abandoned Date
Monday, April 26, 2021
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting the sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting the urogenital organs; Pharmaceuticals and medicines affecting the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Apr 26, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 26, 2021
Abandonment - No Use Statement Filed
Sep 12, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 11, 2020
Extension 5 Granted
Sep 9, 2020
Extension 5 Filed
Sep 9, 2020
Teas Extension Received
Mar 17, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2020
Extension 4 Granted
Mar 13, 2020
Extension 4 Filed
Mar 13, 2020
Teas Extension Received
Sep 18, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2019
Extension 3 Granted
Sep 16, 2019
Extension 3 Filed
Sep 16, 2019
Teas Extension Received
Mar 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2019
Extension 2 Granted
Mar 1, 2019
Extension 2 Filed
Mar 1, 2019
Teas Extension Received
Sep 29, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 28, 2018
Extension 1 Granted
Sep 7, 2018
Extension 1 Filed
Sep 18, 2018
Case Assigned To Intent To Use Paralegal
Sep 7, 2018
Teas Extension Received
Mar 20, 2018
Noa E-Mailed - Sou Required From Applicant
Jan 23, 2018
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2018
Published For Opposition
Jan 3, 2018
Assignment Of Ownership Not Updated Automatically
Jan 3, 2018
Notification Of Notice Of Publication E-Mailed
Dec 11, 2017
Approved For Pub - Principal Register
Jul 3, 2017
Report Completed Suspension Check Case Still Suspended
Jan 30, 2017
Teas Change Of Correspondence Received
Jan 3, 2017
Report Completed Suspension Check Case Still Suspended
Jun 24, 2016
Report Completed Suspension Check Case Still Suspended
Jun 23, 2016
Assigned To Lie
Dec 8, 2015
Notification Of Letter Of Suspension E-Mailed
Dec 8, 2015
Letter Of Suspension E-Mailed
Dec 8, 2015
Suspension Letter Written
Dec 3, 2015
Teas/Email Correspondence Entered
Dec 2, 2015
Correspondence Received In Law Office
Dec 2, 2015
Teas Response To Office Action Received
Jun 9, 2015
Notification Of Non-Final Action E-Mailed
Jun 9, 2015
Non-Final Action E-Mailed
Jun 9, 2015
Non-Final Action Written
Jun 4, 2015
Assigned To Examiner
Apr 10, 2015
New Application Office Supplied Data Entered In Tram
Apr 4, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
